Blog

38 Articles

DNA purification
Research
February 27, 2018 • 3 Min

Precision Medicine from the Get-Go for Pancreatic Cancer

Dr. Ben George and colleagues at the Medical College of Wisconsin are using molecular profiling to determine the best chemotherapy for a patient’s pancreatic cancer.

Pancreatic cancer patient Mike Levine is on his bicycle during a training session for the Ironman Triathlon.
Survivor Stories
February 6, 2018 • 3 Min

Chemotherapy to Survive; Fitness to Thrive

Mike Levine switched oncologists to find chemotherapy that works on his pancreatic cancer. After that he was able to compete in the Ironman Triathlon.

pancreatic cancer patient Susan Zbacnik and her husband
Survivor Stories
August 1, 2017 • 6 Min

Taking Nothing For Granted

After Whipple surgery and chemoradiation, Susan Zbacnik had molecular profiling, genetic testing, and joined an Immunotherapy clinical trial.

Dr. Luis Diaz
Research
July 14, 2017 • 5 Min

An Immunotherapy Game Changer

Immunotherapy with Keytruda (pembrolizumab) is approved for use in cancer patients with certain genetic defects in their tumors.

Pancreatic cancer survivor Bill Shrieves
Survivor Stories
January 19, 2017 • 3 Min

I Have Pancreatic Cancer; It Does Not Have Me

Bill Shrieves was ready to start a clinical trial for pancreatic cancer when it was found to have spread. He was successfully treated with FOLFIRINOX.

Hands covered in blue vinyl gloves working in a science lab
Treatments
August 5, 2016 • 3 Min

Working With your Doctor to Find Clinical Trials

Oncologist Dr. Kim A. Reiss explains the importance of clinical trials and family history of cancer when choosing a treatment for pancreatic cancer.

Flasks
Research
July 21, 2016 • 5 Min

Patient-Focused Research to Better Understand Pancreatic Cancer

Dr. Diane Simeone stresses the importance of research and clinical trials to get better results for pancreatic cancer patients.

Petri dish
Research
January 24, 2016 • 5 Min

Precision Promise Places Patients at Center of Research

Dr. Diane Simeone explains the different approach to pancreatic cancer clinical trials taken by the Precision Promise program.